Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats

Brain Research Bulletin

Volumn 73, Issue 4-6, 2007, Pages 301-309

  Slotkin, Theodore A ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescence; Brain development; Chlorpyrifos; Organophosphate insecticides; Preterm labor; Serotonin turnover; Terbutaline; Tocolysis

Indexed keywords

CHLORPYRIFOS; TERBUTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; JUVENILE; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; ANIMALS; BRAIN; CHILD; CHLORPYRIFOS; FEMALE; HUMANS; INSECTICIDES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRESYNAPTIC TERMINALS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TERBUTALINE; TOCOLYTIC AGENTS;

EID: 34249935494     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.04.004     Document Type: Article

References (86)

1. Aldridge J.E., Levin E.D., Seidler F.J., and Slotkin T.A. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 113 (2005) 527-531
2. Aldridge J.E., Meyer A., Seidler F.J., and Slotkin T.A. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 113 (2005) 1027-1031
3. Aldridge J.E., Meyer A., Seidler F.J., and Slotkin T.A. Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Toxicol. Appl. Pharmacol. 203 (2005) 134-144
4. Aldridge J.E., Seidler F.J., Meyer A., Thillai I., and Slotkin T.A. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ. Health Perspect. 111 (2003) 1736-1743
5. Aldridge J.E., Seidler F.J., and Slotkin T.A. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 112 (2004) 148-155
6. Auman J.T., Seidler F.J., Tate C.A., and Slotkin T.A. β-Adrenoceptor-mediated cell signaling in the neonatal heart and liver: responses to terbutaline. Am. J. Physiol. 281 (2001) R1895-R1901
7. Bagchi D., Bagchi M., Hassoun E.A., and Stohs S.J. In vitro and in vivo generation of reactive oxygen species. DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 104 (1995) 129-140
8. Barr D.B., Allen R., Olsson A.O., Bravo R., Caltabiano L.M., Montesano A., Nguyen J., Udunka S., Walden D., Walker R.D., Weerasekera G., Whitehead Jr. R.D., Schober S.E., and Needham L.L. Concentrations of selective metabolites of organophosphorus pesticides in the United States population. Environ. Res. 99 (2005) 314-326
9. Berkowitz G.S., and Papiernik E. Epidemiology of preterm birth. Epidemiol. Rev. 15 (1993) 414-443
10. Blue M.E., and Molliver M.E. 6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat. Dev. Brain Res. 32 (1987) 255-269
11. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., and Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001) 135-172
12. Bouvier G., Seta N., Vigouroux-Villard A., Blanchard O., and Momas I. Insecticide urinary metabolites in nonoccupationally exposed populations. J. Toxicol. Environ. Health 8 (2005) 485-512
13. Campbell C.G., Seidler F.J., and Slotkin T.A. Chlorpyrifos interferes with cell development in rat brain regions. Brain Res. Bull. 43 (1997) 179-189
14. Casida J.E., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 17 (2004) 983-998
15. B. Clancy, B.L. Finlay, R.B. Darlington, K.J.S. Anand, Extrapolating brain development from experimental species to humans. NeuroToxicology, doi:10.1016/j.neuro.2007.01.014, in press.
16. Clark P.M. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur. J. Pediatr. 157 (1998) S7-S10
17. 2-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J. Child Neurol. 20 (2005) 876-884
18. Crumpton T.L., Seidler F.J., and Slotkin T.A. Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos?. Dev. Brain Res. 121 (2000) 189-195
19. D'Amelio M., Ricci I., Sacco R., Liu X., D'Agruma L., Muscarella L.A., Guarnieri V., Militerni R., Bravaccio C., Elia M., Schneider C., Melmed R., Trillo S., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Macciardi F., Holden J.J.A., and Persico A.M. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol. Psychiatr. 10 (2005) 1006-1016
20. Dam K., Garcia S.J., Seidler F.J., and Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 116 (1999) 9-20
21. Dodic M., Peers A., Coghlan J.P., May C.N., Lumbers E., Yu Z.Y., and Wintour E.M. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin. Sci. 97 (1999) 103-109
22. Dodic M., Samuel C., Moritz K., Wintour E.M., Morgan J., Grigg L., and Wong J. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ. Res. 89 (2001) 623-629
23. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., Morga N., and Jewell N.P. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect. 115 (2007) 792-798
24. Fenske R.A., Black K.G., Elkner K.P., Lee C., Methner M.M., and Soto R. Potential exposure and health risks of infants following indoor residential pesticide applications. Am. J. Pub. Health 80 (1990) 689-693
25. Fenske R.A., Lu C.S., Barr D., and Needham L. Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. Environ. Health Perspect. 110 (2002) 549-553
26. Frost D.O., and Cadet J.L. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res. Rev. 34 (2000) 103-118
27. Furlong C.E., Cole T.B., Jarvik G.P., Pettan-Brewer C., Geiss G.K., Richter R.J., Shih D.M., Tward A.D., Lusis A.J., and Costa L.G. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology 26 (2005) 651-659
28. Garofolo M.C., Seidler F.J., Cousins M.M., Tate C.A., Qiao D., and Slotkin T.A. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res. Bull. 59 (2003) 319-329
29. Goldenberg R.L. The management of preterm labor. Obstet. Gynecol. 100 (2002) 1020-1037
30. Gupta R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol. Mech. Meth. 14 (2004) 103-143
31. Gurunathan S., Robson M., Freeman N., Buckley B., Roy A., Meyer R., Bukowski J., and Lioy P.J. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ. Health Perspect. 106 (1998) 9-16
32. Hamon M., Nelson D.L., Mallat M., and Bourgoin S. Are 5-HT receptors involoved in the sprouting of serotonergic terminals following neonatal 5,7-dihydroxytryptamine treatment in the rat?. Neurochem. Int. 3 (1981) 69-79
33. Izdebska-Straszak G., Gubala E., Jedrzejowska-Szypulka H., Klencki M., Wiczkowski A., and Jarzab B. Permanent effects of postnatal administration of β-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats. Neuroendocrinol. Lett. 27 (2006) 105-113
34. James S.J., Slikker W., Melnyk S., New E., Pogribna M., and Jernigan S. Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology 26 (2005) 1-8
35. Jett D.A., and Navoa R.V. In vitro and in vivo effects of chlorpyrifos on glutathione peroxidase and catalase in developing rat brain. Neurotoxicology 21 (2000) 141-145
36. Khan I.Y., Lakasing L., Poston L., and Nicolaides K.H. Fetal programming for adult disease: where next?. J. Maternal Fetal Neonatal Med. 13 (2003) 292-299
37. Koch D., Lu C., Fisker-Andersen J., Jolley L., and Fenske R.A. Temporal association of children's pesticide exposure and agricultural spraying: report of a longitudinal biological monitoring study. Environ. Health Perpsect. 110 (2002) 829-833
38. Kostrzewa R.M., and Garey R.E. Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa. Brain Res. 124 (1977) 385-391
39. Kudlacz E.M., Navarro H.A., Eylers J.P., Dobbins S.S., Lappi S.E., and Slotkin T.A. Selective linkage of β-adrenergic receptors to functional responses in developing rat lung and liver: phosphatidic acid phosphatase, ornithine decarboxylase and lung liquid reabsorption. J. Dev. Physiol. 12 (1989) 129-134
40. Kudlacz E.M., Navarro H.A., and Slotkin T.A. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J. Pharmacol. Exp. Ther. 250 (1989) 236-240
41. Lackland D.T., Egan B.M., and Ferguson P.L. Low birth weight as a risk factor for hypertension. J. Clin. Hypertension 5 (2003) 133-136
42. Lam F., Bergauer N.K., Jacques D., Coleman S.K., and Stanziano G.J. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J. Perinatol. 21 (2001) 444-450
43. Lam F., Elliott J., Jones J.S., Katz M., Knuppel R.A., Morrison J., Newman R., Phelan J., and Willcourt R. Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstet. Gynecol. Surv. 53 (1998) S85-S95
44. Lam F., Istwan N.B., Jacques D., Coleman S.K., and Stanziano G.J. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Managed Care 12 (2003) 39-46
45. Landrigan P.J., Claudio L., Markowitz S.B., Berkowitz G.S., Brenner B.L., Romero H., Wetmur J.G., Matte T.D., Gore A.C., Godbold J.H., and Wolff M.S. Pesticides and inner-city children: exposures, risks, and prevention. Environ. Health Perspect. 107 Suppl. 3 (1999) 431-437
46. Lewis R., Mercer B.M., Salama M., Walsh M.A., and Sibai B.M. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am. J. Obstet. Gynecol. 175 (1996) 834-837
47. Mackness B., Durrington P.N., and Mackness M.I. The paraoxonase gene family and coronary heart disease. Curr. Opin. Lipidol. 13 (2002)
48. Meyer A., Seidler F.J., Aldridge J.E., and Slotkin T.A. Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide, chlorpyrifos. Toxicol. Appl. Pharmacol. 203 (2005) 154-166
49. Navarro H.A., Kudlacz E.M., and Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate 60 (1991) 127-136
50. Nyirenda M.J., and Seckl J.R. Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure. Int. J. Mol. Med. 2 (1998) 607-614
51. Olanow C.W., and Arendash G.W. Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7 (1994) 548-558
52. Ostrea E.M., Morales V., Ngoumgna E., Prescilla R., Tan E., Hernandez E., Ramirez G.B., Cifra H.L., and Manlapaz M.L. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis. Neurotoxicology 23 (2002) 329-339
53. Phillips D.I.W. Endocrine programming and fetal origins of adult disease. Trends Endocrinol. Metab. 13 (2002) 363
54. Pitzer M., Schmidt M.H., Esser G., and Laucht M. Child development after maternal tocolysis with β-sympathomimetic drugs. Child Psychiatr. Hum. Dev. 31 (2001) 165-182
55. Qiao D., Seidler F.J., and Slotkin T.A. Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicol. Appl. Pharmacol. 206 (2005) 17-26
56. Raines K.W., Seidler F.J., and Slotkin T.A. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Dev. Brain Res. 130 (2001) 65-72
57. Rauh V.A., Garfinkel R., Perera R., Andrews H., Hoepner L., Barr D., Whitehead D., Tang D., and Whyatt R.M. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118 (2006) 1845-1859
58. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., and Colucci W.S. β-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ. Res. 92 (2003) 136-138
59. Rhodes M.C., Seidler F.J., Abdel-Rahman A., Tate C.A., Nyska A., Rincavage H.L., and Slotkin T.A. Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus and somatosensory cortex. J. Pharmacol. Exp. Ther. 308 (2004) 529-537
60. Rhodes M.C., Seidler F.J., Qiao D., Tate C.A., Cousins M.M., and Slotkin T.A. Does pharmacotherapy for preterm labor sensitize the developing brain to environmental neurotoxicants? Cellular and synaptic effects of sequential exposure to terbutaline and chlorpyrifos in neonatal rats. Toxicol. Appl. Pharmacol. 195 (2004) 203-217
61. Rodier P.M. Structural-functional relationships in experimentally induced brain damage. Prog. Brain Res. 73 (1988) 335-348
62. Rust O.A., Bofill J.A., Arriola R.M., Andrew M.E., and Morrison J.C. The clinical efficacy of oral tocolytic therapy. Am. J. Obstet. Gynecol. 175 (1996) 838-842
63. Slikker W., and Schwetz B.A. Childhood obesity: the possible role of maternal smoking and impact on public health. J. Child. Health 1 (2003) 29-40
64. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 107 Suppl. 1 (1999) 71-80
65. Slotkin T.A. Developmental neurotoxicity of organophosphates: a case study of chlorpyrifos. In: Gupta R.C. (Ed). Toxicity of Organophosphate and Carbamate Pesticides (2005), Elsevier Academic Press, San Diego 293-314
66. Slotkin T.A., Auman J.T., and Seidler F.J. Ontogenesis of β-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J. Pharmacol. Exp. Ther. 306 (2003) 1-7
67. Slotkin T.A., Cousins M.M., Tate C.A., and Seidler F.J. Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res. 902 (2001) 229-243
68. Slotkin T.A., Oliver C.A., and Seidler F.J. Critical periods for the role of oxidative stress in the developmental neurotoxicity of chlorpyrifos and terbutaline, alone or in combination. Dev. Brain Res. 157 (2005) 172-180
69. Slotkin T.A., and Seidler F.J. The alterations in CNS serotonergic mechanisms caused by neonatal chlorpyrifos exposure are permanent. Dev. Brain Res. 158 (2005) 115-119
70. Slotkin T.A., and Seidler F.J. Prenatal chlorpyrifos exposure elicits presynaptic serotonergic and dopaminergic hyperactivity at adolescence: critical periods for regional and sex-selective effects. Reprod. Toxicol. 23 (2007) 421-427
71. Slotkin T.A., Seidler F.J., and Ali S.F. Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res. 879 (2000) 163-173
72. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. β-Adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Dev. Brain Res. 131 (2001) 113-125
73. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Dev. Brain Res. 133 (2002) 163-173
74. Song X., Seidler F.J., Saleh J.L., Zhang J., Padilla S., and Slotkin T.A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 145 (1997) 158-174
75. Szpir M. New thinking on neurodevelopment. Environ. Health Perspect. 114 (2006) A101-A107
76. Tanaka J., Toku K., Zhang B., Isihara K., Sakanaka M., and Maeda N. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28 (1999) 85-96
77. Tegner K., Nilsson H.T., Persson C.G.A., Persson K., and Ryrfeldt A. Elimination pathways of terbutaline. Eur. J. Resp. Dis. 65 Suppl. 134 (1984) 93-100
78. Thornton J.G. Maintenance tocolysis. Br. J. Obstet. Gynaecol. 1 (2005) 118-121
79. Toschke A.M., Koletzko B., Slikker W., Hermann M., and von Kries R. Childhood obesity is associated with maternal smoking in pregnancy. Eur. J. Pediatr. 161 (2002) 445-448
80. U.S. Environmental Protection Agency, Administrator's Announcement, 2000, available: http://www.epa.gov/pesticides/announcement6800.htm (accessed update 13 October 2004).
81. U.S. Environmental Protection Agency, Chlorpyrifos: End-Use Products Cancellation Order, 2002, available: http://www.epa.gov/fedrgstr/EPA-PEST/2002/January/Day-25/p1764.htm (accessed 6 December 2004).
82. von Kries R., Toschke A.M., Koletzko B., and Slikker Jr. W. Maternal smoking during pregnancy and childhood obesity. Am. J. Epidemiol. 156 (2002) 954-961
83. Whitney K.D., Seidler F.J., and Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol. Appl. Pharmacol. 134 (1995) 53-62
84. Xu Z., Seidler F.J., Ali S.F., Slikker W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res. 914 (2001) 166-178
85. Yanai J. Neurobehavioral Teratology (1984), Elsevier, Amsterdam
86. Yanai J., Vatury O., and Slotkin T.A. Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann. N.Y. Acad. Sci. 965 (2002) 473-478